Zuventus Healthcare Limited, Mumbai
Paras Shah is an experienced professional with a strong background in digital initiatives, business development, and marketplace operations. Currently serving as Assistant Manager of Digital Initiatives at Zuventus Healthcare Limited since July 2023, Paras previously held the role of Category Manager at SOSH, where key achievements included onboarding major brands and creating growth strategies in the Health & Wellness sector. As Manager of Business Development at Nutrova, Paras launched operations on multiple marketplaces and significantly increased revenue. Notably, Paras founded Blakship Global LLP and launched ELEVARE Coffee, demonstrating entrepreneurial skills and market strategy execution. Paras holds an M.B.A. in Finance from FLAME University and has completed an Advance Certificate in Foreign Trade, reflecting a robust educational foundation in business and finance.
This person is not in the org chart
Zuventus Healthcare Limited, Mumbai
The journey of Zuventus Healthcare began in 2002 when a visionary with pharmaceutical expertise instituted a pharma venture for developing therapeutic products that would improve people’s health, aid faster recovery, and empower them to lead quality lives. The mainstays of this concept were – paramount emphasis on quality, ethics, compliance to standards in operations, and making affordable medicines. A concept whose foundations were as strong as these and which was driven by an unshakeable conviction to care for life inevitably reaches its goal. From 400 employees in 2002 to 3000+ employees today, Zuventus Healthcare is the fastest growing pharma company in India with effective and robust product lines covering a range of therapeutic segments including anti-infectives, vitamins/minerals/nutrients, respiratory generics, gastrointestinal, cardiac, gynaecological, pain/analgesic, antidiabetic, cephalosporins and more available in multiple dosages forms such as tablets, capsules, injectables, and liquids. Zuventus has strong manufacturing capabilities based in Jammu, Sikkim, and Bengaluru as well as a DSIR-approved, advanced formulation R & D centre in Pune. Zuventus’s stupendous growth is evident from the fact that – the company crossed the “100-crore” mark in April 2006, the “200-crore” mark in September 2007 and were quick to achieve a turnover of 2000 crores in 20 years. Today, the company is ranked 7th in the directly covered market and overall ranked 23rd amongst the leading pharmaceutical companies in India. As we propel ahead, we will continue to push the boundaries, invest in research and technology to develop drugs and vaccines for improving patients’ wellbeing.